<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04539704</url>
  </required_header>
  <id_info>
    <org_study_id>2019-598-NSU</org_study_id>
    <nct_id>NCT04539704</nct_id>
  </id_info>
  <brief_title>Assessing Impacts of Static Magnetic Fields on Peripheral Pulses and Skin Blood Flow</brief_title>
  <official_title>Assessing Impacts of Static Magnetic Fields on Peripheral Pulses and Skin Blood Flow</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nova Southeastern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nova Southeastern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to investigate and determine the effects of static&#xD;
      magnetic fields produced by a small magnet on peripheral pulses and skin blood flow.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A specific neodymium magnet and sham device will be placed on certain sites near the ulnar&#xD;
      and medial arteries and the effect of such placement on peripheral pulses assessed via PPG on&#xD;
      fingers and on skin blood flow via laser Doppler perfusion determined. These assessments will&#xD;
      be made while healthy subjects are lying supine on a padded examination table over a time&#xD;
      interval of about 45-60 minutes. In addition to the impact that either the magnet or the sham&#xD;
      devices have, the pulse and skin blood flow patterns and features will be analyzed from the&#xD;
      point of view of sequential variability with and eye toward developing related parameters to&#xD;
      potentially improve such variability.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Subjects and coinvestigators making measurements are blinded to which devices are the active magnets and which are the sham magnets. Only the PI will have that information.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of magnet on skin blood flow</measure>
    <time_frame>one hour</time_frame>
    <description>skin blood flow</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of magnet on arterial pulses</measure>
    <time_frame>one hour</time_frame>
    <description>Pulse values and paterns</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Characterization of temporal pattern of pulse changes and their amelioration</measure>
    <time_frame>one hour</time_frame>
    <description>variability with and without normalization</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Arterial Stiffness</condition>
  <condition>Magnetic Field Exposure</condition>
  <condition>Peripheral Arterial Disease</condition>
  <arm_group>
    <arm_group_label>Healthy Adults-magnet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy adults with magnet and/or sham</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Adults-sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Healthy adults with magnet and/or sham</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>magnet and sham</intervention_name>
    <description>In same subject some areas will have magnet and others will have sham</description>
    <arm_group_label>Healthy Adults-magnet</arm_group_label>
    <arm_group_label>Healthy Adults-sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age between 18-35 years&#xD;
&#xD;
          2. No known neurological deficit&#xD;
&#xD;
          3. No known cardiovascular condition&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Unable or unwilling to lie reasonably still for about 55 minutes&#xD;
&#xD;
          2. Known to have diabetes of any type&#xD;
&#xD;
          3. Having any metallic or wire implant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Harvey Mayrovitz</last_name>
    <phone>9547429921</phone>
    <email>mayrovit@nova.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nova Southeastern University</name>
      <address>
        <city>Davie</city>
        <state>Florida</state>
        <zip>33328</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harvey Mayrovitz</last_name>
      <phone>954-205-7199</phone>
      <email>mayrovit@nova.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>August 31, 2020</study_first_submitted>
  <study_first_submitted_qc>August 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 7, 2020</study_first_posted>
  <last_update_submitted>June 7, 2021</last_update_submitted>
  <last_update_submitted_qc>June 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nova Southeastern University</investigator_affiliation>
    <investigator_full_name>Harvey Mayrovitz</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

